SITM vs. BBIO
SITM (SiTime Corporation) and BBIO (BridgeBio Pharma, Inc.) are both stocks. SITM operates in Semiconductors (Technology), while BBIO operates in Biotechnology (Healthcare). Over the past 5 years, SITM returned 31.59%/yr vs 8.42%/yr for BBIO. Their 0.32 correlation means their historical movements had little consistent relationship.
Performance
SITM vs. BBIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SITM achieves a 51.53% return, which is significantly higher than BBIO's 4.71% return.
SITM
- 1D
- 1.39%
- 1M
- -23.96%
- 6M
- 47.39%
- YTD
- 51.53%
- 1Y
- 163.84%
- 3Y*
- 58.81%
- 5Y*
- 31.59%
- 10Y*
- —
- ALL TIME*
- 74.26%
BBIO
- 1D
- -2.50%
- 1M
- 7.47%
- 6M
- 3.65%
- YTD
- 4.71%
- 1Y
- 69.43%
- 3Y*
- 32.71%
- 5Y*
- 8.42%
- 10Y*
- —
- ALL TIME*
- 14.52%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $163.36M | $283.28M | $252.33M | |
| $238.88M | $264.90M | $400.80M |
SITM vs. BBIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
SITM SiTime Corporation | 51.53% | 64.63% | 75.73% | 20.13% | -65.26% | 161.36% | 338.94% | 96.15% |
BBIO BridgeBio Pharma, Inc. | 4.71% | 178.75% | -32.03% | 429.79% | -54.32% | -76.54% | 102.88% | 15.71% |
Correlation
The correlation between SITM and BBIO is 0.19, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.19 |
Correlation (3Y) Balances recent behavior with more history. | 0.29 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.33 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2019 | 0.32 |
The correlation between SITM and BBIO shifts across timeframes, from 0.19 (1 year) to 0.33 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
SITM:
$14.13B
BBIO:
$15.69B
SITM:
-$0.92
BBIO:
-$3.74
SITM:
37.22
BBIO:
27.48
SITM:
$379.91M
BBIO:
$566.04M
SITM:
$211.60M
BBIO:
$538.20M
SITM:
-$13.71M
BBIO:
-$602.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SITM vs. BBIO — Risk / Return Rank
SITM
BBIO
SITM vs. BBIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SiTime Corporation (SITM) and BridgeBio Pharma, Inc. (BBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SITM | BBIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.61 | ||
| Sortino ratioReturn per unit of downside risk | +0.51 | ||
| Omega ratioGain probability vs. loss probability | 1.32 | 1.28 | +0.03 |
| Calmar ratioReturn relative to maximum drawdown | 3.38 | 3.45 | -0.06 |
| Martin ratioReturn relative to average drawdown | 10.14 | 7.74 | +2.39 |
Loading charts...
Drawdowns
SITM vs. BBIO - Drawdown Comparison
The maximum SITM drawdown since its inception was -78.12%, smaller than the maximum BBIO drawdown of -92.80%. Use the drawdown chart below to compare losses from any high point for SITM and BBIO.
Loading charts...
Drawdown Indicators
| SITM | BBIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.12% | -92.80% | +14.68% |
Max Drawdown (1Y)Largest decline over 1 year | -48.73% | -20.25% | -28.48% |
Max Drawdown (3Y)Largest decline over 3 years | -55.26% | -49.08% | -6.18% |
Max Drawdown (5Y)Largest decline over 5 years | -78.12% | -90.72% | +12.60% |
Current DrawdownCurrent decline from peak | -40.63% | -11.18% | -29.45% |
Average DrawdownAverage peak-to-trough decline | -36.64% | -45.08% | +8.44% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.24% | 9.00% | +7.24% |
Volatility
SITM vs. BBIO - Volatility Comparison
SiTime Corporation (SITM) has a higher volatility of 27.75% compared to BridgeBio Pharma, Inc. (BBIO) at 17.23%. This indicates that SITM's price experiences larger fluctuations and is considered to be riskier than BBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SITM | BBIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 27.75% | 17.23% | +10.52% |
Volatility (6M)Calculated over the trailing 6-month period | 62.42% | 37.06% | +25.36% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.71% | 48.65% | +32.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.22% | 86.05% | -8.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 80.69% | 83.29% | -2.60% |
Dividends
SITM vs. BBIO - Dividend Comparison
Neither SITM nor BBIO has paid dividends to shareholders.
Financials
SITM vs. BBIO - Financials Comparison
This section allows you to compare key financial metrics between SiTime Corporation and BridgeBio Pharma, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
SITM vs. BBIO - Profitability Comparison
SITM - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, SiTime Corporation reported a gross profit of 66.96M and revenue of 113.57M. Therefore, the gross margin over that period was 59.0%.
BBIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, BridgeBio Pharma, Inc. reported a gross profit of 178.39M and revenue of 180.60M. Therefore, the gross margin over that period was 98.8%.
SITM - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, SiTime Corporation reported an operating income of -12.34M and revenue of 113.57M, resulting in an operating margin of -10.9%.
BBIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, BridgeBio Pharma, Inc. reported an operating income of -105.96M and revenue of 180.60M, resulting in an operating margin of -58.7%.
SITM - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, SiTime Corporation reported a net income of -5.22M and revenue of 113.57M, resulting in a net margin of -4.6%.
BBIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, BridgeBio Pharma, Inc. reported a net income of -164.04M and revenue of 180.60M, resulting in a net margin of -90.8%.
Frequently Asked Questions
SITM and BBIO have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SITM has higher volatility (27.75%) compared to BBIO (17.23%). In terms of maximum drawdown, SITM dropped -78.12% vs BBIO's -92.80%.
SITM currently has the higher Sharpe Ratio (2.04 vs 1.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SITM and BBIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer